Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lemmers Protein Exchange (LPE) is a biotechnology company specializing in a proprietary platform for the site-specific modification and engineering of proteins. The company's core technology, known as Protein Exchange, allows for the precise swapping of protein domains or the attachment of functional groups to specific sites on a protein scaffold. This approach is designed to overcome the limitations of traditional conjugation methods, enabling the development of more stable and homogeneous biologics. LPE collaborates with pharmaceutical partners to apply its technology to various therapeutic areas, including oncology and inflammatory diseases. The company is based in the Netherlands and focuses on providing high-value protein engineering solutions for the biopharmaceutical industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lemmers Protein Exchange.